1. Home
  2. FGEN vs MASK Comparison

FGEN vs MASK Comparison

Compare FGEN & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MASK
  • Stock Information
  • Founded
  • FGEN 1993
  • MASK 2017
  • Country
  • FGEN United States
  • MASK China
  • Employees
  • FGEN N/A
  • MASK N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MASK
  • Sector
  • FGEN Health Care
  • MASK
  • Exchange
  • FGEN Nasdaq
  • MASK NYSE
  • Market Cap
  • FGEN 34.5M
  • MASK 31.7M
  • IPO Year
  • FGEN 2014
  • MASK 2025
  • Fundamental
  • Price
  • FGEN $0.52
  • MASK $2.97
  • Analyst Decision
  • FGEN
  • MASK
  • Analyst Count
  • FGEN 0
  • MASK 0
  • Target Price
  • FGEN N/A
  • MASK N/A
  • AVG Volume (30 Days)
  • FGEN 709.3K
  • MASK 94.5K
  • Earning Date
  • FGEN 02-24-2025
  • MASK 01-01-0001
  • Dividend Yield
  • FGEN N/A
  • MASK N/A
  • EPS Growth
  • FGEN N/A
  • MASK 55.43
  • EPS
  • FGEN N/A
  • MASK 0.15
  • Revenue
  • FGEN $180,015,000.00
  • MASK $4,561,963.00
  • Revenue This Year
  • FGEN $21.91
  • MASK N/A
  • Revenue Next Year
  • FGEN N/A
  • MASK N/A
  • P/E Ratio
  • FGEN N/A
  • MASK $18.08
  • Revenue Growth
  • FGEN 16.15
  • MASK 172.95
  • 52 Week Low
  • FGEN $0.18
  • MASK $2.50
  • 52 Week High
  • FGEN $2.80
  • MASK $3.99
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 53.72
  • MASK N/A
  • Support Level
  • FGEN $0.46
  • MASK N/A
  • Resistance Level
  • FGEN $0.51
  • MASK N/A
  • Average True Range (ATR)
  • FGEN 0.04
  • MASK 0.00
  • MACD
  • FGEN -0.00
  • MASK 0.00
  • Stochastic Oscillator
  • FGEN 78.67
  • MASK 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

Share on Social Networks: